Global Candida Infection Testing Market Report 2026: Emerging Trends and Growth Scenarios
Uncover key drivers, emerging technologies, and competitive movements shaping the candida infection testing market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Candida Infection Testing Market in 2026, and what figure is it projected to hit by 2030?
The candida infection testing market has experienced substantial expansion in its size during recent years. Projections indicate its growth from $16.72 billion in 2025 to $17.8 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. The market’s past development can be attributed to several contributing factors, including the increasing incidence of fungal infections, growth in immunocompromised patient populations, the expansion of hospital diagnostic services, the adoption of culture-based fungal testing, and rising awareness of antifungal resistance.
The candida infection testing market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $22.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. The surge during this forecast period stems from factors such as the heightened demand for swift fungal diagnostic solutions, the increasing embrace of molecular and microbiome testing methodologies, the broader availability of point-of-care fungal testing, growing financial commitments to infectious disease diagnostics, and an intensified emphasis on tailored antifungal therapies. Key trends observed within this period encompass the growing acceptance of molecular candida detection techniques, the increased utilization of rapid NAAT-based testing, the expanding incorporation of microbiome analysis, the proliferation of hospital-based fungal diagnostics, and a sharpened focus on identifying fungal infections at an early stage.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19356&type=smp
Which Drivers Are Affecting Market Participation In The Candida Infection Testing Market?
The anticipated rise in yeast infection cases is set to boost the expansion of the candida infection testing market in the future. Yeast infections are fungal conditions stemming from an excess of candida, frequently impacting areas like the mouth, genitals, and skin, typically leading to symptoms such as itching, redness, and discomfort. These infections primarily arise from the fungus candida proliferating excessively, often triggered by disruptions in the body’s bacterial balance, compromised immune defenses, or shifts in hormone levels. For yeast infections, candida infection testing serves to precisely identify the extent of candida overgrowth, enabling healthcare professionals to confirm the diagnosis and direct suitable treatment strategies. As an illustration, in May 2025, the UK Health Security Agency, a UK-based government public health agency, reported that yeast-related bloodstream infections in England saw a 4% increase in 2024 versus 2023, climbing from 2,170 to 2,247 reported cases, with the rate also rising from 3.8 to 3.9 per 100,000 population during the identical timeframe. Consequently, the escalating occurrence of yeast infections is poised to fuel the expansion of the candida infection testing market.
What Segment Classifications Make Up The Candida Infection Testing Market?
The candida infection testing market covered in this report is segmented –
1) By Type: Invasive Candidiasis, Candidemia
2) By Test Type: Vaginal pH Test, Nucleic Acid Amplification Testing (NAAT), Microbiome Test
3) By Application: Hospital, Laboratory
Subsegments:
1) By Invasive Candidiasis: Tissue Biopsy Testing, Urine Culture Testing, Blood Culture Testing
2) By Candidemia: Blood Tests, Serological Testing, Molecular Testing
Which Trends Are Guiding The Evolution Of The Candida Infection Testing Market?
Companies operating within the candida infection testing market are primarily focused on developing technologically advanced solutions, such as fully automated PCR rapid tests for detecting candida, aiming to enhance diagnostic accuracy and improve patient care. A fully automated PCR rapid test for identifying candida refers to a sophisticated diagnostic tool employing polymerase chain reaction (PCR) technology to quickly and precisely pinpoint the presence of Candida species in clinical specimens. For example, in May 2024, Bosch Healthcare Solutions GmbH, a German medical technology manufacturer, introduced a PCR test for C. auris detection on its Vivalytic platform, which provides fully automated, rapid testing within an hour at the point of care. This advanced test permits swift screenings and differs significantly from traditional culture methods, which require one to three days in centralized labs, consequently delaying diagnosis and treatment. Intended for clinical settings, this test is particularly beneficial for high-risk patients, enabling timely diagnosis and intervention to counter the severe health risks linked to C. auris infections.
Which Major Firms Are Strengthening Their Position In The Candida Infection Testing Market?
Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The Candida Infection Testing Market?
North America was the largest region in the candida infection testing market in 2025. The regions covered in the candida infection testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Candida Infection Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19356&type=smp
Browse Through More Reports Similar to the Global Candida Infection Testing Market 2026, By The Business Research Company
Pseudomonas Aeruginosa Infection Treatment Market Report 2026
High Level Disinfection Services Market Report 2026
Uv Disinfection Equipment Market Report 2026
https://www.thebusinessresearchcompany.com/report/uv-disinfection-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
